Multicenter study evaluating the Vitek MS system for identification of medically important yeasts

Journal of Clinical Microbiology

Volumn 51, Issue 7, 2013, Pages 2267-2272

  Westblade, Lars F ^a,b   Jennemann, Rebecca ^c   Branda, John A ^d   Bythrow, Maureen ^e   Ferraro, Mary Jane ^d   Garner, Omai B ^f   Ginocchio, Christine C ^b,e   Lewinski, Michael A ^f   Manji, Ryhana ^e   Mochon, A Brian ^f   Procop, Gary W ^g   Richter, Sandra S ^g   Rychert, Jenna A ^d   Sercia, Linda ^g   Burnham, Carey Ann D ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DONALD AND BARBARA ZUCKER SCHOOL OF MEDICINE AT HOFSTRA NORTHWELL   (United States)

^c BARNES JEWISH HOSPITAL   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e Department of Pathology and Laboratory Medicine North Shore LIJ Health System Laboratories ^*  (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FORMIC ACID; RIBOSOME RNA; RNA 26S; UNCLASSIFIED DRUG;

ARTICLE; CANDIDA ALBICANS; CANDIDA DUBLINIENSIS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CRYPTOCOCCUS NEOFORMANS; FUNGUS IDENTIFICATION; FUNGUS ISOLATION; GALACTOMYCES GEOTRICHUM; GEOTRICHUM; GEOTRICHUM KLEBAHNII; MASS SPECTROMETER; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MICROBIOLOGY; NONHUMAN; PHENOTYPE; PICHIA ANOMALA; PRIORITY JOURNAL; YEAST; CHEMISTRY; CLASSIFICATION; CLINICAL TRIAL; COMPARATIVE STUDY; DIAGNOSTIC ERROR; DIAGNOSTIC PROCEDURE; EVALUATION STUDY; HUMAN; ISOLATION AND PURIFICATION; MASS SPECTROMETRY; MULTICENTER STUDY; MYCOLOGY; MYCOSES; PROCEDURES; SENSITIVITY AND SPECIFICITY; STATISTICS AND NUMERICAL DATA;

CANDIDA; CANDIDA ALBICANS; CANDIDA DUBLINIENSIS; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; FILOBASIDIELLA NEOFORMANS; GALACTOMYCES GEOTRICHUM; GEOTRICHUM KLEBAHNII; PICHIA ANOMALA;

CLINICAL LABORATORY TECHNIQUES; DIAGNOSTIC ERRORS; HUMANS; MYCOLOGY; MYCOSES; SENSITIVITY AND SPECIFICITY; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; YEASTS;

EID: 84879446498     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00680-13     Document Type: Article

References (36)

1. Arendrup MC, Fisher BT, Zaoutis TE. 2009. Invasive fungal infections in the paediatric and neonatal population: diagnostics and management issues. Clin. Microbiol. Infect. 15:613-624.
2. Muskett H, Shahin J, Eyres G, Harvey S, Rowan K, Harrison D. 2011. Risk factors for invasive fungal disease in critically ill adult patients: a systematic review. Crit. Care 15:R287.
3. Parize P, Rammaert B, Lortholary O. 2012. Emerging invasive fungal diseases in transplantation. Curr. Infect. Dis. Rep. 14:668-675.
4. Shoham S, Marr KA. 2012. Invasive fungal infections in solid organ transplant recipients. Future Microbiol. 7:639-655.
5. Gratwohl A, Baldomero H, Aljurf M, Pasquini MC, Bouzas LF, Yoshimi A, Szer J, Lipton J, Schwendener A, Gratwohl M, Frauendorfer K, Niederwieser D, Horowitz M, Kodera Y. 2010. Hematopoietic stem cell transplantation: a global perspective. JAMA 303:1617-1624.
6. US Department of Health and Human Services. 2013. Statistics and facts for people over 50. http://www.organdonor.gov/about/statistics.html. Accessed 12 February 2013.
7. Garey KW, Rege M, Pai MP, Mingo DE, Suda KJ, Turpin RS, Bearden DT. 2006. Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study. Clin. Infect. Dis. 43:25-31.
8. Pappas PG, Kauffman CA, Andes D, Benjamin DK, Jr, Calandra TF, Edwards JE, Jr, Filler SG, Fisher JF, Kullberg BJ, Ostrosky-Zeichner L, Reboli AC, Rex JH, Walsh TJ, Sobel JD. 2009. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin. Infect. Dis. 48:503-535.
9. Echeverria PM, Kett DH, Azoulay E. 2011. Candida prophylaxis and therapy in the ICU. Semin. Respir. Crit. Care Med. 32:159-173.
10. Andes DR, Safdar N, Baddley JW, Playford G, Reboli AC, Rex JH, Sobel JD, Pappas PG, Kullberg BJ. 2012. Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials. Clin. Infect. Dis. 54:1110-1122.
11. Marcos JY, Pincus DH. 2013. Fungal diagnostics: review of commercially available methods. Methods Mol. Biol. 968:25-54.
12. Pincus DH, Orenga S, Chatellier S. 2007. Yeast identification: past, present, and future methods. Med. Mycol. 45:97-121.
13. Freydiere AM, Odds FC. 2001. Commercial kits for yeast identification: concerns for standardisation. Eur. J. Clin. Microbiol. Infect. Dis. 20:366-367.
14. Freydiere AM, Guinet R, Boiron P. 2001. Yeast identification in the clinical microbiology laboratory: phenotypical methods. Med. Mycol. 39: 9-33.
15. Verweij PE, Breuker IM, Rijs AJ, Meis JF. 1999. Comparative study of seven commercial yeast identification systems. J. Clin. Pathol. 52:271-273.
16. Walsh TJ, Groll A, Hiemenz J, Fleming R, Roilides E, Anaissie E. 2004. Infections due to emerging and uncommon medically important fungal pathogens. Clin. Microbiol. Infect. 10(Suppl 1):48-66.
17. Sanguinetti M, Porta R, Sali M, La Sorda M, Pecorini G, Fadda G, Posteraro B. 2007. Evaluation of VITEK 2 and RapID yeast plus systems for yeast species identification: experience at a large clinical microbiology laboratory. J. Clin. Microbiol. 45:1343-1346.
18. Fenselau C, Demirev PA. 2001. Characterization of intact microorganisms by MALDI mass spectrometry. Mass Spectrom. Rev. 20:157-171.
19. Iriart X, Lavergne RA, Fillaux J, Valentin A, Magnaval JF, Berry A, Cassaing S. 2012. Routine identification of medical fungi by the new Vitek MS matrix-assisted laser desorption ionization-time of flight system with a new time-effective strategy. J. Clin. Microbiol. 50:2107-2110.
20. Hall L, Wohlfiel S, Roberts GD. 2003. Experience with the MicroSeq D2 large-subunit ribosomal DNA sequencing kit for identification of commonly encountered, clinically important yeast species. J. Clin. Microbiol. 41:5099-5102.
21. Hata DJ, Hall L, Fothergill AW, Larone DH, Wengenack NL. 2007. Multicenter evaluation of the new VITEK 2 advanced colorimetric yeast identification card. J. Clin. Microbiol. 45:1087-1092.
22. Erhard M, Hipler UC, Burmester A, Brakhage AA, Wostemeyer J. 2008. Identification of dermatophyte species causing onychomycosis and tinea pedis by MALDI-TOF mass spectrometry. Exp. Dermatol. 17:356-361.
23. Marinach-Patrice C, Lethuillier A, Marly A, Brossas JY, Gene J, Symoens F, Datry A, Guarro J, Mazier D, Hennequin C. 2009. Use of mass spectrometry to identify clinical Fusarium isolates. Clin. Microbiol. Infect. 15:634-642.
24. Marklein G, Josten M, Klanke U, Muller E, Horre R, Maier T, Wenzel T, Kostrzewa M, Bierbaum G, Hoerauf A, Sahl HG. 2009. Matrixassisted laser desorption ionization-time of flight mass spectrometry for fast and reliable identification of clinical yeast isolates. J. Clin. Microbiol. 47:2912-2917.
25. Stevenson LG, Drake SK, Shea YR, Zelazny AM, Murray PR. 2010. Evaluation of matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of clinically important yeast species. J. Clin. Microbiol. 48:3482-3486.
26. Bader O, Weig M, Taverne-Ghadwal L, Lugert R, Gross U, Kuhns M. 2011. Improved clinical laboratory identification of human pathogenic yeasts by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Clin. Microbiol. Infect. 17:1359-1365.
27. Dhiman N, Hall L, Wohlfiel SL, Buckwalter SP, Wengenack NL. 2011. Performance and cost analysis of matrix-assisted laser desorption ionization-time of flight mass spectrometry for routine identification of yeast. J. Clin. Microbiol. 49:1614-1616.
28. Posteraro B, Vella A, Cogliati M, De Carolis E, Florio AR, Posteraro P, Sanguinetti M, Tortorano AM. 2012. Matrix-assisted laser desorption ionization-time of flight mass spectrometry-based method for discrimination between molecular types of Cryptococcus neoformans and Cryptococcus gattii. J. Clin. Microbiol. 50:2472-2476.
29. Yaman G, Akyar I, Can S. 2012. Evaluation of the MALDI TOF-MS method for identification of Candida strains isolated from blood cultures. Diagn. Microbiol. Infect. Dis. 73:65-67.
30. Tan KE, Ellis BC, Lee R, Stamper PD, Zhang SX, Carroll KC. 2012. Prospective evaluation of a matrix-assisted laser desorption ionizationtime of flight mass spectrometry system in a hospital clinical microbiology laboratory for identification of bacteria and yeasts: a bench-by-bench study for assessing the impact on time to identification and costeffectiveness. J. Clin. Microbiol. 50:3301-3308.
31. Moran GP, Sullivan DJ, Henman MC, McCreary CE, Harrington BJ, Shanley DB, Coleman DC. 1997. Antifungal drug susceptibilities of oral Candida dubliniensis isolates from human immunodeficiency virus (HIV)-infected and non-HIV-infected subjects and generation of stable fluconazole-resistant derivatives in vitro. Antimicrob. Agents Chemother. 41:617-623.
32. Beyda ND, Lewis RE, Garey KW. 2012. Echinocandin resistance in Candida species: mechanisms of reduced susceptibility and therapeutic approaches. Ann. Pharmacother. 46:1086-1096.
33. Goyer M, Lucchi G, Ducoroy P, Vagner O, Bonnin A, Dalle F. 2012. Optimization of the preanalytical steps of matrix-assisted laser desorption ionization-time of flight mass spectrometry identification provides a flexible and efficient tool for identification of clinical yeast isolates in medical laboratories. J. Clin. Microbiol. 50:3066-3068.
34. Cassagne C, Cella AL, Suchon P, Normand AC, Ranque S, Piarroux R. 2013. Evaluation of four pretreatment procedures for MALDI-TOF MS yeast identification in the routine clinical laboratory. Med. Mycol. 51:371-377.
35. Theel ES, Schmitt BH, Hall L, Cunningham SA, Walchak RC, Patel R, Wengenack NL. 2012. Formic acid-based direct, on-plate testing of yeast and Corynebacterium species by Bruker Biotyper matrix-assisted laser desorption ionization-time of flight mass spectrometry. J. Clin. Microbiol. 50:3093-3095.
36. Byrnes EJ, III, Bartlett KH, Perfect JR, Heitman J. 2011. Cryptococcus gattii: an emerging fungal pathogen infecting humans and animals. Microbes Infect. 13:895-907.